Results 171 to 180 of about 180,511 (184)

Tiny lives, big failures: India's drug regulation crisis. [PDF]

Lancet Reg Health Southeast Asia
The Lancet Regional Health-Southeast Asia.
europepmc   +1 more source

Guidelines for safe and effective management and use of point of care testing in primary and community care

, 2010
Irish Medicines Board (IMB)
core  

Some of the next articles are maybe not open access.

Related searches:

Evaluating Low-Cost Optical Spectrometers for the Detection of Simulated Substandard and Falsified Medicines

Applied Spectroscopy, 2020
Wenbo Wang, Benjamin K Wilson, Matthew D Keller   +2 more
exaly  

A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives

2022
Tim Ken Mackey, Laura Modica de Mohac, Bahijja Raimi-Abraham   +2 more
exaly  

A risk classification model for prioritising the management of quality issues relating to substandard medicines in Singapore

Pharmacoepidemiology and Drug Safety, 2022
Pei San Ang, Sreemanee Raaj Dorajoo, Yi Long Toh   +2 more
exaly  

Substandard medicines in resource-poor settings: a problem that can no longer be ignored

Tropical Medicine and International Health, 2008
Nathan Ford
exaly  

Generic medicines are not substandard medicines

Lancet, The, 2002
Ellen 't Hoen
exaly   +2 more sources

Tackling Substandard and Falsified Medicines in the Mekong: National Responses and Regional Prospects

Asia and the Pacific Policy Studies, 2015
Marco Liverani
exaly  

Unveiling the Peril of Substandard and Falsified Medicines to Public Health and Safety in Africa: Need for All-Out War to End the Menace

Medicine Access Point of Care, 2017
Abdulhakim Abubakar, Abubakar Sha'aban, Nafiu Aminu   +2 more
exaly  

People also looked at

Frontiers in Pharmacology, 2018
Ulrike Holzgrabe
exaly